Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Tocotrienol supplements significantly increased hair growth in people with hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

TCM is an effective and safe treatment for primary cicatricial alopecias.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib effectively treats Alopecia Areata.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

TCDD changes skin cell growth and keratin production in mice.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.